GV1001 is a peptide consisting of 16 amino acids derived from the catalytic subunit of human telomerase reverse transcriptase. A recent phase II clinical trial in patients with Alzheimer disease (AD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results